Success Story: From Genetic Discovery to NIW Approval: A Biomedical Scientist’s Case for Advancing Personalized Medicine
Client’s Testimonial:
“Thanks a lot for your support throughout the process. It's been a great experience working with your team!”
On April 13th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Student in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Graduate Student
Country of Origin: Bangladesh
State of Residence at the Time of Filing: New York
Approval Notice Date: April 13th, 2026
Processing Time: 20 months, 12 days (Premium Processing Upgrade Requested)
Case Summary:
Our firm recently secured I-140 NIW approval for the client, a professional in biomedical science with an M.S. in genetics engineering and biotechnology. In presenting this case, we focused on a proposed endeavor that was both forward-looking and clearly tied to important U.S. interests. The client’s work centers on using genetic and genomic methodologies to investigate the molecular pathophysiology of neurodegenerative diseases and other genetic diseases, with the goal of establishing a stronger foundation for personalized medicine and advancing therapeutic strategies.
To show national importance, we did not rely on general statements about science or healthcare. Instead, we explained why this line of research matters in practical terms. By studying disease mechanisms at the genetic and genomic level, the client’s work supports earlier detection, more targeted interventions, and treatment strategies tailored to individual patients. In the petition, we connected this work to the broader challenge posed by neurodegenerative diseases and showed how advances in this area can improve patient outcomes while also helping reduce the long-term healthcare burden.
The client’s record provided concrete support for that argument. She had authored 4 peer-reviewed journal articles, and her publications had been cited a total of 35 times. We presented these metrics not as numbers that speak for themselves, but as evidence of developing influence in a specialized field. In particular, the citation record showed that other researchers had already relied on her findings in their own work, which is often one of the clearest indicators that a researcher’s contributions are useful beyond her own projects.
Another helpful feature of the case was evidence of external support. The client’s research had received funding from the Ministry of Science and Technology, Republic of Bangladesh. We used that funding evidence to reinforce that her work had already attracted institutional backing, which supported the argument that her research agenda addressed meaningful scientific problems.
This approval reflects the strength of a case built around a well-defined endeavor, a credible record of research, and a careful explanation of how the client’s past work supported her future plans. We are delighted that the client’s I-140 NIW was approved and look forward to her continued contributions to biomedical science and personalized medicine.